|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
573,600,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$179.79 - $179.79 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Belldegrun Arie |
Chairman, President and CEO |
|
2016-12-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
66,000 |
1,607,750 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-12-01 |
4 |
AS |
$50.68 |
$76,134 |
D/D |
(1,500) |
15,811 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-12-01 |
4 |
OE |
$6.89 |
$10,335 |
D/D |
1,500 |
17,311 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-11-25 |
4 |
AS |
$50.37 |
$504,015 |
D/D |
(10,000) |
95,477 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-11-25 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
105,477 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-11-10 |
4 |
AS |
$50.62 |
$506,467 |
D/D |
(10,000) |
95,477 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-11-10 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
105,477 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-11-10 |
4 |
AS |
$50.18 |
$75,270 |
D/D |
(1,500) |
15,811 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-11-10 |
4 |
OE |
$6.89 |
$10,335 |
D/D |
1,500 |
17,311 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-10-03 |
4 |
AS |
$54.72 |
$82,214 |
D/D |
(1,500) |
15,811 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-10-03 |
4 |
OE |
$6.89 |
$10,335 |
D/D |
1,500 |
17,311 |
|
- |
|
Kazam Joshoa A |
Director |
|
2016-09-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
215,000 |
1,950 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-09-26 |
4 |
AS |
$54.13 |
$541,300 |
D/D |
(10,000) |
95,477 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-09-26 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
105,477 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-09-01 |
4 |
AS |
$58.17 |
$87,362 |
D/D |
(1,500) |
15,811 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-09-01 |
4 |
OE |
$6.89 |
$10,335 |
D/D |
1,500 |
17,311 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-08-25 |
4 |
AS |
$58.03 |
$582,775 |
D/D |
(10,000) |
95,477 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-08-25 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
105,477 |
|
- |
|
Kim Helen Susan |
EVP, Business Development |
|
2016-08-15 |
4 |
AS |
$63.01 |
$151,229 |
D/D |
(2,400) |
9,000 |
|
- |
|
Kim Helen Susan |
EVP, Business Development |
|
2016-08-15 |
4 |
OE |
$51.43 |
$123,432 |
D/D |
2,400 |
11,400 |
|
- |
|
Kim Helen Susan |
EVP, Business Development |
|
2016-08-12 |
4 |
AS |
$60.08 |
$2,012,596 |
D/D |
(33,500) |
9,000 |
|
- |
|
Kim Helen Susan |
EVP, Business Development |
|
2016-08-12 |
4 |
OE |
$51.43 |
$1,722,905 |
D/D |
33,500 |
42,500 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-08-01 |
4 |
AS |
$56.66 |
$85,343 |
D/D |
(1,500) |
14,867 |
|
- |
|
Wiezorek Jeffrey |
SVP Clinical Development |
|
2016-08-01 |
4 |
OE |
$6.89 |
$10,335 |
D/D |
1,500 |
16,367 |
|
- |
|
Butitta Cynthia M |
Chief Operating Officer |
|
2016-07-25 |
4 |
AS |
$50.94 |
$509,350 |
D/D |
(10,000) |
95,401 |
|
- |
|
387 Records found
|
|
Page 8 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|